AAAAAA
Results: 1-25/43
Authors:
Mehilli, J
Kastrati, A
Dirschinger, J
Dotzer, F
Schuhlen, H
Fleckenstein, M
Neumann, FJ
Schomig, A
Citation: J. Mehilli et al., A randomized trial comparing the hand-mounted JoStent with the premounted Multi-Link Duet stent in patients with coronary artery disease, CATHET C IN, 54(4), 2001, pp. 414-419
Authors:
Kastrati, A
Dirschinger, J
Schomig, A
Citation: A. Kastrati et al., Restenosis in one lesion in patients with multilesion stenting occurs evenwhen the companion lesion is free of restenosis, CATHET C IN, 53(2), 2001, pp. 287-287
Authors:
Schuhlen, H
Kastrati, A
Schomig, A
Citation: H. Schuhlen et al., Structural failure of a coronary stent, HEART, 86(1), 2001, pp. 26-26
Authors:
Kastrati, A
Schuhlen, H
Schomig, A
Citation: A. Kastrati et al., Stenting for small coronary vessels: A contestable winner, J AM COL C, 38(6), 2001, pp. 1604-1607
Authors:
Schuhlen, H
Kastrati, A
Pache, J
Dirschinger, J
Schomig, A
Citation: H. Schuhlen et al., Incidence of thrombotic occlusion and major adverse cardiac events betweentwo and four weeks after coronary stent placement: Analysis of 5,678 patients with a four-week ticlopidine regimen, J AM COL C, 37(8), 2001, pp. 2066-2073
Authors:
Kastrati, A
Schomig, A
Citation: A. Kastrati et A. Schomig, Good medicines for bad genes, EUR HEART J, 22(7), 2001, pp. 523-525
Authors:
Neumann, FJ
Kastrati, A
Miethke, T
Pogatsa-Murray, G
Mehilli, J
Valina, C
Jogethaei, N
da Costa, CP
Wagner, H
Schomig, A
Citation: Fj. Neumann et al., Treatment of Chlamydia pneumoniae infection with roxithromycin and effect on neointima proliferation after coronary stent placement (ISAR-3): a randomised, double-blind, placebo-controlled trial, LANCET, 357(9274), 2001, pp. 2085-2089
Authors:
Koch, W
Kastrati, A
Bottiger, C
Mehilli, J
von Beckerath, N
Schomig, A
Citation: W. Koch et al., Interleukin-10 and tumor necrosis factor gene polymorphisms and risk of coronary artery disease and myocardial infarction, ATHEROSCLER, 159(1), 2001, pp. 137-144
Authors:
von Beckerath, N
Koch, W
Mehilli, J
Bottiger, C
Braun, S
Schomig, A
Kastrati, A
Citation: N. Von Beckerath et al., Glycoprotein Ia CX07T polymorphism and risk of restenosis following coronary stenting, ATHEROSCLER, 156(2), 2001, pp. 463-468
Authors:
Neumann, FJ
Kastrati, A
Miethke, T
Mehilli, J
Pogatsa-Murray, G
Koch, W
Seyfarth, M
Schomig, A
Citation: Fj. Neumann et al., Previous cytomegalovirus infection and restenosis after coronary stent placement, CIRCULATION, 104(10), 2001, pp. 1135-1139
Authors:
Kastrati, A
Mehilli, J
Dirschinger, J
Dotzer, F
Schuhlen, H
Neumann, FJ
Fleckenstein, M
Pfafferott, C
Seyfarth, M
Schomig, A
Citation: A. Kastrati et al., Intracoronary stenting and angiographic results - Strut thickness effect on restenosis outcome (ISAR-STEREO) trial, CIRCULATION, 103(23), 2001, pp. 2816-2821
Authors:
Koch, W
Bottiger, C
Mehilli, J
von Beckerath, N
Neumann, FJ
Schomig, A
Kastrati, A
Citation: W. Koch et al., Association of a CD18 gene polymorphism with a reduced risk of restenosis after coronary stenting, AM J CARD, 88(10), 2001, pp. 1120-1124
Authors:
Schuhlen, H
Kastrati, A
Pache, J
Dirschinger, J
Schomig, A
Citation: H. Schuhlen et al., Sustained benefit over four years from an initial combined antiplatelet regimen after coronary stent placement in the ISAR trial, AM J CARD, 87(4), 2001, pp. 397-400
Authors:
Scuhlen, H
Eigler, N
Whiting, JS
Haubner, R
Hausleiter, J
Dirschinger, J
Kastrati, A
Schwaiger, M
Schomig, A
Citation: H. Scuhlen et al., Usefulness of intracoronary brachytherapy for in-stent restenosis with a Re-188 liquid-filled balloon, AM J CARD, 87(4), 2001, pp. 463
Authors:
Kastrati, A
Mehilli, J
Dirschinger, J
Pache, J
Ulm, K
Schuhlen, H
Seyfarth, M
Schmitt, C
Blasini, R
Neumann, FJ
Schomig, A
Citation: A. Kastrati et al., Restenosis after coronary placement of various stent types, AM J CARD, 87(1), 2001, pp. 34-39
Authors:
Kastrati, A
Dirschinger, J
Boekstegers, P
Elezi, S
Schuhlen, H
Pache, J
Steinbeck, G
Schmitt, C
Ulm, K
Neumann, FJ
Schomig, A
Citation: A. Kastrati et al., Influence of stent design on 1-year outcome after coronary stent placement: A randomized comparison of five stent types in 1,147 unselected patients, CATHET C IN, 50(3), 2000, pp. 290-297
Authors:
Kastrati, A
Koch, W
Berger, PB
Mehilli, J
Stephenson, K
Neumann, FJ
von Beckerath, N
Bottiger, C
Duff, GW
Schomig, A
Citation: A. Kastrati et al., Protective role against restenosis from an interleukin-1 receptor antagonist gene polymorphism in patients treated with coronary stenting, J AM COL C, 36(7), 2000, pp. 2168-2173
Authors:
Kastrati, A
Koch, W
Gawaz, M
Mehilli, J
Bottiger, C
Schomig, K
von Beckerath, N
Schomig, A
Citation: A. Kastrati et al., Pl(A) polymorphism of glycoprotein IIIa and risk of adverse events after coronary stent placement, J AM COL C, 36(1), 2000, pp. 84-89
Intracoronary steinting or angioplasty for restenosis reduction in small arteries (ISAR-SMART) trial
Authors:
Kastrati, A
Citation: A. Kastrati, Intracoronary steinting or angioplasty for restenosis reduction in small arteries (ISAR-SMART) trial, J AM COL C, 36(1), 2000, pp. 313-313
Authors:
Neumann, FJ
Kastrati, A
Schmitt, C
Blasini, R
Hadamitzky, M
Mehilli, J
Gawaz, M
Schleef, M
Seyfarth, M
Dirschinger, J
Schomig, A
Citation: Fj. Neumann et al., Effect of glycoprotein IIb/IIIa receptor blockade with abciximab on clinical and angiographic restenosis rate after the placement of coronary stents following acute myocardial infarction, J AM COL C, 35(4), 2000, pp. 915-921
Authors:
Kastrati, A
Dirschinger, J
Schomig, A
Citation: A. Kastrati et al., Genetic risk factors and restenosis after percutaneous coronary interventions (vol 25, pg 34, 2000), HERZ, 25(2), 2000, pp. 153-153
Authors:
Kastrati, A
Dirschinger, J
Schomig, A
Citation: A. Kastrati et al., Genetic risk factors and restenosis after percutaneous coronary interventions, HERZ, 25(1), 2000, pp. 34-46
Authors:
Bottiger, C
Kastrati, A
Koch, W
Mehilli, J
Seidl, H
Schomig, K
von Beckerath, N
Schomig, A
Citation: C. Bottiger et al., HPA-1 and HPA-3 polymorphisms of the platelet fibrinogen receptor and coronary artery disease and myocardial infarction, THROMB HAEM, 83(4), 2000, pp. 559-562
Authors:
Mehilli, J
Kastrati, A
Dirschinger, J
Bollwein, H
Neumann, FJ
Schomig, A
Citation: J. Mehilli et al., Differences in prognostic factors and outcomes between women and men undergoing coronary artery stenting, J AM MED A, 284(14), 2000, pp. 1799-1805
Authors:
Schomig, A
Kastrati, A
Dirschinger, J
Mehilli, J
Schricke, U
Pache, J
Martinoff, S
Neumann, FJ
Schwaiger, M
Citation: A. Schomig et al., Coronary stenting plus platelet glycoprotein IIb/IIIa blockade compared with tissue plasminogen activator in acute myocardial infarction, N ENG J MED, 343(6), 2000, pp. 385-391